Evidence map›Paper›PMID 42611994›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Select intratumoral riboflavin-auxotrophic

Pakhi Birla, Lansaol Yang, Wanting Shan, Sakura Minamisawa, Omkar Dhaygude, Haritha Manoj, Alex J Lee, Jacqueline Ferri, Ying Zheng, Andrew Northcutt and 8 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Pakhi BirlaSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.ORCID 0000-0002-7252-5717
Lansaol YangSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.
Wanting ShanSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.
Sakura MinamisawaDepartment of Pathology and Oncology, Faculty of Medicine, Juntendo University, Tokyo 113-842, Japan.ORCID 0009-0002-6204-7413
Omkar DhaygudeDepartment of Mechanical Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD 21218.
Haritha ManojSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.
Alex J LeeSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.ORCID 0000-0002-1825-2439
Jacqueline FerriSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.ORCID 0009-0009-4340-6936
Ying ZhengSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.ORCID 0000-0002-4107-6752
Andrew NorthcuttSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.ORCID 0000-0001-5118-1217
Hongni FanSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.
Hadley BeauregardDepartment of Medicine, Division of Infectious Disease, Johns Hopkins University, Baltimore, MD 21205.
Zhen ZengSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.ORCID 0000-0002-3443-0637
Kellie N SmithSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.
Fyza Y ShaikhSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.ORCID 0000-0001-7839-8483
Cynthia L SearsBloomberg ~ Kimmel Institute for Cancer Immunotherapy, Johns Hopkins School of Medicine, Baltimore, MD 21205.ORCID 0000-0003-4059-1661
Drew M PardollSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.ORCID 0000-0001-6215-1013
Franck HousseauSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.ORCID 0000-0002-7028-3953

Funding

Commonwealth Foundation for Cancer Research Foundation CommonwealthJHU | Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University | Bloomberg ~ Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University (Bloomberg ~ Kimmel Institute for Cancer Immunotherapy) BKI
6 · The paper itself

Abstract

Mucosal-associated invariant T (MAIT) cells are innate-like T cells capable of MR1-dependent immune surveillance, but how intratumoral bacteria modulate MR1 expression in human lung tumors remains unclear. We studied intratumoral MAIT cells from paired single-cell RNA and TCR sequencing datasets of tumor-infiltrating CD3 T cells isolated from non-small cell lung cancer tumors in patients receiving neoadjuvant PD-1 blockade therapy. MAIT cells were subclustered to identify conventional MAIT-associated TCR clonotypes, which were then used to examine how bacterial exposure impacts cell-surface MR1 expression and downstream MAIT TCR activation. We found that select intratumoral

Indexed as

Carcinoma, Non-Small-Cell LungEnterococcusHistocompatibility Antigens Class ILung NeoplasmsMinor Histocompatibility AntigensMucosal-Associated Invariant T CellsReceptors, Antigen, T-CellRiboflavinHumansLymphocyte ActivationRibitolUracil5-(2-oxopropylideneamino)-6-d-ribitylaminouracilHistocompatibility Antigens Class IMinor Histocompatibility AntigensMR1 protein, humanReceptors, Antigen, T-CellRibitolRiboflavinUracilEnterococcusMAITMR1tumor microbiome

Identifiers

PMID42611994
PMCPMC13506043

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.